Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2013 | 2 |
2015 | 1 |
2016 | 1 |
2021 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169.
N Engl J Med. 2023.
PMID: 38055253
Clinical Trial.
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018).
Arend RC, Monk BJ, Shapira-Frommer R, Haggerty AF, Alvarez EA, Amit A, Alvarez Secord A, Muller C, Casado Herraez A, Herzog TJ, Tewari KS, Cohen JG, Huang M, Yachnin A, Holeman LL, Ledermann JA, Rachmilewitz Minei T, Buyse M, Fain Shmueli S, Lavi M, Harats D, Penson RT; OVAL/GOG-3018 Investigators.
Arend RC, et al. Among authors: yachnin a.
J Clin Oncol. 2024 Jan 10;42(2):170-179. doi: 10.1200/JCO.22.02915. Epub 2023 Oct 31.
J Clin Oncol. 2024.
PMID: 37906726
Clinical Trial.
Item in Clipboard
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer.
Konecny GE, Hendrickson AEW, Davidson TM, Winterhoff BJ, Ma S, Mahner S, Sehouli J, Fasching PA, Feisel-Schwickardi G, Poelcher M, Roman LD, Rody A, Karlan BY, Mullany SA, Chen H, Ray-Coquard IL, Provencher DM, Yachnin A, Cottu PH, Glaspy JA, Haluska P, Slamon DJ.
Konecny GE, et al. Among authors: yachnin a.
Gynecol Oncol. 2021 Dec;163(3):465-472. doi: 10.1016/j.ygyno.2021.09.025. Epub 2021 Oct 9.
Gynecol Oncol. 2021.
PMID: 34642026
Free article.
Clinical Trial.
Item in Clipboard
Epistaxis during treatment with paclitaxel.
Yarom N, Cyjon A, Kovel S, Yachnin A, Sella A, Evron E.
Yarom N, et al. Among authors: yachnin a.
Basic Clin Pharmacol Toxicol. 2009 Mar;104(3):259-61. doi: 10.1111/j.1742-7843.2008.00372.x. Epub 2009 Jan 22.
Basic Clin Pharmacol Toxicol. 2009.
PMID: 19191781
Free article.
Clinical Trial.
Item in Clipboard
Pretreatment CA 15-3 levels do not predict disease-free survival in patients with advanced epithelial ovarian cancer.
Gemer O, Oustinov N, Gdalevich M, Dubnik S, Levy R, Yachnin A, Lavie O, Ben Baruch N, Ben Arie A.
Gemer O, et al. Among authors: yachnin a.
Tumori. 2013 Mar-Apr;99(2):257-60. doi: 10.1177/030089161309900222.
Tumori. 2013.
PMID: 23748823
Item in Clipboard
The Added Value of SPECT/CT in Sentinel Lymph Nodes Mapping for Endometrial Carcinoma.
Naaman Y, Pinkas L, Roitman S, Ikher S, Oustinov N, Vaisbuch E, Yachnin A, Ben-Arie A.
Naaman Y, et al. Among authors: yachnin a.
Ann Surg Oncol. 2016 Feb;23(2):450-5. doi: 10.1245/s10434-015-4877-5. Epub 2015 Oct 5.
Ann Surg Oncol. 2016.
PMID: 26438438
Item in Clipboard
Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experience.
Safra T, Berman T, Yachnin A, Bruchim I, Meirovitz M, Barak F, Atlas I, Levy T, Rosengarten OS.
Safra T, et al. Among authors: yachnin a.
Int J Gynecol Cancer. 2013 Mar;23(3):475-80. doi: 10.1097/IGC.0b013e3182866944.
Int J Gynecol Cancer. 2013.
PMID: 23435437
Clinical Trial.
Item in Clipboard
Cite
Cite